ANIP logo

ANI Pharmaceuticals (ANIP) CAPEX

Annual CAPEX

$18.51 M
+$2.06 M+12.49%

31 December 2023

ANIP CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$5.44 M
+$994.00 K+22.34%

30 September 2024

ANIP Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$19.25 M
+$890.00 K+4.85%

30 September 2024

ANIP TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIP CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.5%+19.6%+14.1%
3 y3 years-72.9%+833.6%-24.2%
5 y5 years+69.6%+181.7%-29.2%

ANIP CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-72.9%+12.5%-44.5%+1379.1%-24.2%+332.6%
5 y5 years-72.9%+69.6%-90.5%+1379.1%-71.8%+332.6%
alltimeall time-87.6%>+9999.0%-93.6%-89.0%>+9999.0%

ANI Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$5.44 M(+22.3%)
$19.25 M(+4.8%)
June 2024
-
$4.45 M(-2.9%)
$18.36 M(-11.5%)
Mar 2024
-
$4.58 M(-4.1%)
$20.74 M(+12.0%)
Dec 2023
$18.51 M(+12.5%)
$4.78 M(+5.0%)
$18.51 M(+9.7%)
Sept 2023
-
$4.55 M(-33.3%)
$16.87 M(-23.8%)
June 2023
-
$6.83 M(+190.1%)
$22.14 M(+33.1%)
Mar 2023
-
$2.35 M(-25.1%)
$16.63 M(+1.1%)
Dec 2022
$16.45 M(-30.4%)
$3.14 M(-68.0%)
$16.45 M(+20.3%)
Sept 2022
-
$9.81 M(+642.9%)
$13.68 M(+207.4%)
June 2022
-
$1.32 M(-39.3%)
$4.45 M(-82.3%)
Mar 2022
-
$2.18 M(+491.8%)
$25.08 M(+6.1%)
Dec 2021
$23.64 M(-65.4%)
$368.00 K(-36.9%)
$23.64 M(-6.9%)
Sept 2021
-
$583.00 K(-97.3%)
$25.39 M(-17.1%)
June 2021
-
$21.95 M(+2878.3%)
$30.61 M(+165.9%)
Mar 2021
-
$737.00 K(-65.2%)
$11.51 M(-83.1%)
Dec 2020
$68.32 M(+148.0%)
$2.12 M(-63.5%)
$68.32 M(+1.1%)
Sept 2020
-
$5.81 M(+104.0%)
$67.58 M(+6.1%)
June 2020
-
$2.85 M(-95.1%)
$63.70 M(-1.7%)
Mar 2020
-
$57.55 M(+4088.2%)
$64.81 M(+135.3%)
Dec 2019
$27.55 M(+152.5%)
$1.37 M(-28.9%)
$27.55 M(+1.4%)
Sept 2019
-
$1.93 M(-51.2%)
$27.18 M(+2.1%)
June 2019
-
$3.96 M(-80.5%)
$26.62 M(-7.9%)
Mar 2019
-
$20.29 M(+1914.4%)
$28.92 M(+165.0%)
Dec 2018
$10.91 M(-89.9%)
$1.01 M(-26.6%)
$10.91 M(-81.8%)
Sept 2018
-
$1.37 M(-78.1%)
$60.02 M(-1.8%)
June 2018
-
$6.25 M(+174.6%)
$61.13 M(+6.9%)
Mar 2018
-
$2.28 M(-95.5%)
$57.18 M(-47.1%)
Dec 2017
$107.99 M(-27.6%)
$50.12 M(+1920.8%)
$107.99 M(+82.2%)
Sept 2017
-
$2.48 M(+7.6%)
$59.27 M(+2.4%)
June 2017
-
$2.30 M(-95.7%)
$57.88 M(-50.4%)
Mar 2017
-
$53.09 M(+3722.5%)
$116.60 M(-21.8%)
Dec 2016
$149.06 M(+356.1%)
$1.39 M(+27.5%)
$149.06 M(+0.2%)
Sept 2016
-
$1.09 M(-98.2%)
$148.78 M(-14.7%)
June 2016
-
$61.03 M(-28.7%)
$174.46 M(+53.5%)
Mar 2016
-
$85.55 M(+7642.2%)
$113.62 M(+247.6%)
Dec 2015
$32.68 M(-8.6%)
$1.10 M(-95.9%)
$32.68 M(+2.4%)
Sept 2015
-
$26.77 M(>+9900.0%)
$31.92 M(+15.3%)
June 2015
-
$198.00 K(-95.7%)
$27.68 M(-0.2%)
Mar 2015
-
$4.61 M(+1264.5%)
$27.73 M(-22.4%)
Dec 2014
$35.75 M(>+9900.0%)
$338.00 K(-98.5%)
$35.75 M(+0.9%)
Sept 2014
-
$22.53 M(+8804.3%)
$35.45 M(+173.7%)
June 2014
-
$253.00 K(-98.0%)
$12.95 M(+1.0%)
Mar 2014
-
$12.63 M(>+9900.0%)
$12.83 M(+6615.2%)
Dec 2013
$191.00 K(-68.8%)
$29.00 K(-14.7%)
$191.00 K(-21.9%)
Sept 2013
-
$34.00 K(-73.4%)
$244.50 K(-63.8%)
June 2013
-
$128.00 K(+55.2%)
$675.90 K(+10.6%)
Dec 2012
$611.20 K
$82.50 K(-82.3%)
$611.20 K(+1.4%)
Sept 2012
-
$465.40 K(+5014.3%)
$603.00 K(+150.9%)
DateAnnualQuarterlyTTM
June 2012
-
$9100.00(-83.2%)
$240.30 K(-56.5%)
Mar 2012
-
$54.20 K(-27.1%)
$552.90 K(-23.2%)
Dec 2011
$719.90 K(+1035.5%)
$74.30 K(-27.7%)
$719.90 K(+5.9%)
Sept 2011
-
$102.70 K(-68.1%)
$680.10 K(+16.8%)
June 2011
-
$321.70 K(+45.4%)
$582.50 K(+110.4%)
Mar 2011
-
$221.20 K(+541.2%)
$276.80 K(+336.6%)
Dec 2010
$63.40 K(-61.7%)
$34.50 K(+576.5%)
$63.40 K(+53.9%)
Sept 2010
-
$5100.00(-68.1%)
$41.20 K(+12.0%)
June 2010
-
$16.00 K(+105.1%)
$36.80 K(+76.9%)
Mar 2010
-
$7800.00(-36.6%)
$20.80 K(-87.4%)
Dec 2009
$165.70 K(-74.6%)
$12.30 K(+1657.1%)
$165.70 K(-70.0%)
Sept 2009
-
$700.00(>+9900.0%)
$551.70 K(-18.3%)
June 2009
-
$0.00(-100.0%)
$675.10 K(-14.5%)
Mar 2009
-
$152.70 K(-61.7%)
$789.20 K(+21.2%)
Dec 2008
$651.10 K(+2114.6%)
$398.30 K(+221.0%)
$651.10 K(+137.5%)
Sept 2008
-
$124.10 K(+8.8%)
$274.20 K(+81.7%)
June 2008
-
$114.10 K(+681.5%)
$150.90 K(+243.0%)
Mar 2008
-
$14.60 K(-31.8%)
$44.00 K(+49.7%)
Dec 2007
$29.40 K(-25.2%)
$21.40 K(+2575.0%)
$29.40 K(+267.5%)
Sept 2007
-
$800.00(-88.9%)
$8000.00(-81.2%)
June 2007
-
$7200.00(>+9900.0%)
$42.50 K(+8.4%)
Dec 2006
$39.30 K(-41.7%)
$0.00(-100.0%)
$39.20 K(-35.4%)
Sept 2006
-
$35.30 K(+938.2%)
$60.70 K(+119.9%)
June 2006
-
$3400.00(+580.0%)
$27.60 K(-31.2%)
Mar 2006
-
$500.00(-97.7%)
$40.10 K(-40.6%)
Dec 2005
$67.40 K(-34.7%)
$21.50 K(+877.3%)
$67.50 K(-12.5%)
Sept 2005
-
$2200.00(-86.2%)
$77.10 K(-9.0%)
June 2005
-
$15.90 K(-43.0%)
$84.70 K(-15.9%)
Mar 2005
-
$27.90 K(-10.3%)
$100.70 K(-2.3%)
Dec 2004
$103.20 K(+1059.6%)
$31.10 K(+217.3%)
$103.10 K(+35.1%)
Sept 2004
-
$9800.00(-69.3%)
$76.30 K(+7.3%)
June 2004
-
$31.90 K(+5.3%)
$71.10 K(+81.4%)
Mar 2004
-
$30.30 K(+604.7%)
$39.20 K(+340.4%)
Dec 2003
$8900.00(-77.2%)
$4300.00(-6.5%)
$8900.00(+1.1%)
Sept 2003
-
$4600.00(+9.5%)
$8800.00(-77.4%)
Dec 2002
$39.00 K(-55.0%)
$4200.00(-53.3%)
$39.00 K(-13.7%)
Sept 2002
-
$9000.00(-2.2%)
$45.20 K(-49.8%)
June 2002
-
$9200.00(-44.6%)
$90.00 K(-11.1%)
Mar 2002
-
$16.60 K(+59.6%)
$101.20 K(+16.7%)
Dec 2001
$86.70 K(+100.7%)
$10.40 K(-80.7%)
$86.70 K(-1.5%)
Sept 2001
-
$53.80 K(+163.7%)
$88.00 K(+129.2%)
June 2001
-
$20.40 K(+871.4%)
$38.40 K(+12.9%)
Mar 2001
-
$2100.00(-82.1%)
$34.00 K(-21.3%)
Dec 2000
$43.20 K(+928.6%)
$11.70 K(+178.6%)
$43.20 K(+37.1%)
Sept 2000
-
$4200.00(-73.8%)
$31.50 K(+15.4%)
June 2000
-
$16.00 K(+41.6%)
$27.30 K(+141.6%)
Mar 2000
-
$11.30 K
$11.30 K
Dec 1999
$4200.00(-96.6%)
-
-
Dec 1998
$125.00 K
-
-

FAQ

  • What is ANI Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual CAPEX year-on-year change?
  • What is ANI Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is ANI Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM CAPEX year-on-year change?

What is ANI Pharmaceuticals annual capital expenditures?

The current annual CAPEX of ANIP is $18.51 M

What is the all time high annual CAPEX for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual capital expenditures is $149.06 M

What is ANI Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, ANIP annual capital expenditures has changed by +$2.06 M (+12.49%)

What is ANI Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of ANIP is $5.44 M

What is the all time high quarterly CAPEX for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly capital expenditures is $85.55 M

What is ANI Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, ANIP quarterly capital expenditures has changed by +$890.00 K (+19.55%)

What is ANI Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of ANIP is $19.25 M

What is the all time high TTM CAPEX for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM capital expenditures is $174.46 M

What is ANI Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, ANIP TTM capital expenditures has changed by +$2.38 M (+14.09%)